Back

Micro-costing for national-scale azithromycin mass drug administration to improve child survival in Niger

2026-02-11 health economics Title + abstract only
View on medRxiv
Show abstract

As programs for azithromycin mass drug administration to reduce child mortality have begun in some parts of West Africa, it is imperative to understand their financial costs. We combined a micro-costing framework and observations from an implementation-focused sub-study within the AVENIR trials in 80 communities in the Dosso region of Niger to estimate the national health sector costs of a scaled-up programmatic approach for azithromycin biannual distribution to children aged 1-59 months of age ...

Predicted journal destinations